Skip to main content
. 2021 Sep 30;12:738230. doi: 10.3389/fgene.2021.738230

FIGURE 3.

FIGURE 3

Combination therapies targeting DDR pathways. (A) Inhibition of PARP1 leads to the conversion of SSBs into DSBs upon DNA replication. (B) An overview of NHEJ, TMEJ and HR and inhibitors targeting various components of these pathways.